英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
401260查看　401260　在百度字典中的解释百度英翻中〔查看〕
401260查看　401260　在Google字典中的解释Google英翻中〔查看〕
401260查看　401260　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Careers - Cytoreason
    It’s a common problem in drug development Biologists and bioinformaticians don’t understand each other We tackle this from day 1 at CytoReason
  • Company - Cytoreason
    You can then use these insights to prioritize new targets, find biomarkers, profile combinations and much much more Ever-growing and ever-updating, CytoReason’s disease models simplify complex molecular mechanisms and illegible disease readouts, making them understandable to researchers of all levels, in any organization
  • Technology - Cytoreason
    The latest and greatest Created by top immunologists and backed by top-tier publications Couldn’t be more specific Broken down by disease AND tissue, and even by patient population disease severity Inside Out Every disease layer is linked to its clinical and molecular features, with tools like cell-level and network analysis Bigger and better data Ever-growing and […]
  • Job opportunity:
    Develop and implement deep learning algorithms to analyze high-dimensional molecular and clinical datasets Collaborate with biologists and bioinformaticians to uncover insights into disease mechanisms and progression
  • Poolbeg Pharma reaches R D milestone as partner CytoReason completes AI . . .
    Poolbeg will then aim to monetise the assets through partnerships and licensing deals with pharma and biotech Poolbeg’s capital-light model is nonstandard as it aims to develop and bring products through to early human proof of concept in the clinic, then partner with large players in the industry that continue the pipeline to production and distribution
  • CytoReason Secures $80M from OurCrowd, NVIDIA, Pfizer, and Thermo . . .
    CytoReason Secures $80M from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific to Scale Its AI Disease Models and Establish US Hub in Cambridge, Massachusetts
  • Revolutionizing IBD Treatment: The CytoReason and CCF Partnership
    Inflammatory Bowel disease (IBD) is a generalized name for two chronic inflammatory conditions in the gastrointestinal tract – Ulcerative Colitis and Crohn’s Disease
  • Home - Cytoreason
    Think of it as the most comprehensive model of human diseases Modeling and comparing treatments and patient groups so you get a clear map of disease and drug mechanisms
  • CytoReason Disease Model
    The CytoReason platform integrates different types of data from various diseases, treatments, and patient groups With a unified standard and a common language for all our disease models, you can easily upload your own data, ask questions across treatments and compare assets across different indications and patient populations
  • Resources - Cytoreason
    CytoReason and the Crohn’s Colitis Foundation Forge Groundbreaking Data Collaboration to Advance IBD Research





中文字典-英文字典  2005-2009